Inari Medical (NARI) continues to gain from its expanded product portfolio. However, continued loss at the operating level raises concern.
On June 17, 2024, Director William Hoffman executed a significant transaction by selling 40,000 shares of Inari Medical Inc (NASDAQ:NARI). The shares were sold at a price of $43.54 each, as detailed in the SEC Filing. Following this transaction, the insider now owns 825,359 shares of the company.
Key Insights The projected fair value for Inari Medical is US$40.36 based on 2 Stage Free Cash Flow to Equity With...